Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

ImmunoGen Inc (NASDAQ:IMGN)

5.09
Delayed Data
As of 3:59pm ET
 +0.11 / +2.21%
Today’s Change
1.51
Today|||52-Week Range
6.21
+149.51%
Year-to-Date

Today’s Trading

Previous close4.98
Today’s open5.18
Day’s range5.05 - 5.30
Volume2,290,450
Average volume (3 months)2,049,014
Market cap$445.0M
Dividend yield--
Data as of 3:59pm ET, 05/24/2017

Growth & Valuation

Earnings growth (last year)-135.21%
Earnings growth (this year)--
Earnings growth (next 5 years)+15.00%
Revenue growth (last year)-29.86%
P/E ratioNM
Price/Sales4.46
Price/Book--

Competitors

 Today’s
change
Today’s
% change
GERNGeron Corp-0.02-0.65%
BCRXBioCryst Pharmaceuti...-0.02-0.39%
BOLDAudentes Therapeutic...-0.39-2.27%
NTLAIntellia Therapeutic...+0.18+1.26%
Data as of 3:59pm ET, 05/24/2017

Financials

Next reporting dateJuly 28, 2017
EPS forecast (this quarter)-$0.40
Annual revenue (last year)$60.0M
Annual profit (last year)-$144.8M
Net profit margin-241.35%

Profile

Sector
Health Technology
Industry
Biotechnology
President, Chief Executive Officer &
Director
Mark J. Enyedy
Chief Financial Officer &
Executive Vice President
David B. Johnston
Corporate headquarters
Waltham, Massachusetts

Forecasts